Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects

被引:187
作者
Fernández-Real, JM
Broch, M
Vendrell, J
Richart, C
Ricart, V
机构
[1] Univ Hosp Girona Dr Josep Trueta, Unitat Diabetol Endocrinol & Nutr, Girona 17007, Spain
[2] Univ Rovira & Virgili, Fac Med, Hosp Tarragona Joan XXIII, Unitat Endocrinol, Tarragona 43007, Spain
关键词
D O I
10.1210/jc.85.3.1334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several lines of evidence indicate that interleukin-6 (IL-6) is involved not only in the hepatic acute phase response but also in adipose tissue metabolism, lipoprotein lipase activity, and hepatic triglyceride secretion. A polymorphism in the IL-6 gene, associated with differences in IL-6 transcription rate, has been recently described. We aimed to study whether this IL-6 gene polymorphism leads to differences in fasting and postglucose load plasma lipids in healthy subjects. Subjects with G at position - 174 of the IL-6 gene were similar in age, sex, body mass index, and waist to hip ratio in comparison with carriers of the C allele. However, G carriers showed almost twice plasma triglycerides (1.5 +/- 0.9 us. 0.90 +/- 0.37 mmol/L; P = 0.01), very low-density lipoprotein (VLDL)-triglycerides (0.97 +/- 0.69 us. 0.42 +/- 0.2 mmol/L; P = 0.002), higher fasting (881 us. 458 lambda mol/L; P = 0.01), and postglucose load free fatty acids (299 vs. 90.5 mu mol/L; P = 0.03), slightly lower high-density lipoprotein-2 cholesterol (0.25 +/- 0.14 us. 0.39 +/- 0.26 mmol/L; P = 0.058), and similar cholesterol and LDL-cholesterol levels than carriers of the C allele. Serum IL-6 levels correlated positively with fasting triglycerides, VLDL-triglycerides, and postload free fatty acids (r = 0.61, 0.65 and 0.60, respectively; P < 0.001) and negatively with high-density lipoprotein-cholesterol (r = -0.42, P < 0.05). A tendency toward higher serum IL-6 levels was observed among G carriers (9.9 +/- 6.9 us. 6.85 +/- 1.7 pg/mL; P = 0.09). The - 174G construct was recently reported to show higher expression of IL-6 in He La cells and was associated with higher plasma IL-6 levels than the - 174C allele. Thus, the results of the present study suggest that subjects with the G allele, associated to higher IL-6 secretion, are prone to lipid abnormalities. Whether this polymorphism contributes to lipid alterations associated with ether metabolic disorders awaits additional studies.
引用
收藏
页码:1334 / 1339
页数:6
相关论文
共 22 条
[1]   Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors [J].
Baggio, G ;
Donazzan, S ;
Monti, D ;
Mari, D ;
Martini, S ;
Gabelli, C ;
Dalla Vestra, M ;
Previato, L ;
Guido, M ;
Pigozzo, S ;
Cortella, I ;
Crepaldi, G ;
Franceschi, C .
FASEB JOURNAL, 1998, 12 (06) :433-437
[2]   Insulin resistance and inflammation in an evolutionary perspective:: the contribution of cytokine genotype/phenotype to thriftiness [J].
Fernández-Real, JM ;
Ricart, W .
DIABETOLOGIA, 1999, 42 (11) :1367-1374
[3]   Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects [J].
Fernández-Real, JM ;
Gutiérrez, C ;
Ricart, W ;
Castiñeira, MJ ;
Vendrell, J ;
Richart, C .
ATHEROSCLEROSIS, 1999, 146 (02) :321-327
[4]   The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels [J].
FernandezReal, JM ;
Gutierrez, C ;
Ricart, W ;
Casamitjana, R ;
FernandezCastaner, M ;
Vendrell, J ;
Richart, C ;
Soler, J .
DIABETES, 1997, 46 (09) :1468-1472
[5]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376
[6]   Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid [J].
Fried, SK ;
Bunkin, DA ;
Greenberg, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :847-850
[7]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[8]  
GREENBERG AS, 1992, CANCER RES, V52, P4113
[9]  
GRUNFELD C, 1992, DIABETES S2, V41, P97
[10]   Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly [J].
Harris, TB ;
Ferrucci, L ;
Tracy, RP ;
Corti, MC ;
Wacholder, S ;
Ettinger, WH ;
Heimovitz, H ;
Cohen, HJ ;
Wallace, R .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) :506-512